Atmo Biosciences investment by Breakthrough Victoria

Kain Lawyers is proud to have advised Atmo Biosciences on the investment by Breakthrough Victoria. This investment will support the commercialization of the Atmo Biosciences’ world-first ingestible gas-sensing capsule that can help diagnose functional gastrointestinal disorders, which affect almost 40% of Australians. Atmo Biosciences CEO Malcolm Hebblewhite said he was delighted to welcome Breakthrough Victoria as a long-term, strategic investor. The Kain Lawyers deal team was led by Alyce Ricciardi and Gerry Cawson with assistance from Dan Wood. Congratulations to all involved. #transactionspecialists